NCT00604591View on ClinicalTrials.gov

Effects of Tolcapone on Frontotemporal Dementia

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 30, 2008

Primary Completion Date

June 16, 2016

Study Completion Date

June 16, 2016

Conditions
Frontotemporal Lobar Degeneration
Interventions
DRUG

Tolcapone

200 mg by mouth three times a day

DRUG

Placebo

200 mg by mouth three times a day

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Columbia University

OTHER

NCT00604591 - Effects of Tolcapone on Frontotemporal Dementia | Biotech Hunter | Biotech Hunter